Cytotheryx recently paid a combined $7.6 million to buy two Rochester facilities

Cytotheryx recently paid a combined $7.6 million to buy two Rochester facilities

ROCHESTER — Cytotheryx, a growing biotech firm working on treatments for liver disease, recently paid a combined $7.6 million to buy the two Rochester facilities it occupies. Cytotheryx, which uses genetically engineered pigs dubbed “proprietary bio-incubators” to make human liver cells for use in multiple therapeutic applications, purchased a 46-year-old complex at 3400 22nd St. NW from Mayo Clinic on Feb. 26. The company, co-founded in Rochest…